Biopharmaceutical
Section Preps for JSM ‘09
T
he 2009 Joint Statistical Meetings
Invited Sessions
will be held August 1–6 in
August 2, 2:00 p.m. – 3:50 p.m.
Washington, DC. The Bio-
The Statistical Issues Surrounding
pharmaceutical Section, one of the larg-
Progression-Free Survival in Oncology
est sections of the ASA, is sponsoring six
Drug Development
invited sessions, 15 topic-contributed
sessions, and 19 contributed sessions
Sunday, August 2
covering a variety of topics, from the dis-
4:00 p.m. to 5:50 p.m.
covery to the late phase of drug and
Issues and Challenges in
device development. The section also is
Dichotomizing Continuous Variables
sponsoring 18 roundtable with lunch
in Clinical Trials
sessions: six on Monday, six on Tuesday,
and six on Wednesday. Finally, for the
Monday, August 3
benefit of its members, the section has
10:30 a.m. to 12:20 p.m.
organized three Continuing Education
Recent Advances in Missing Data and
(CE) classes on relevant topics in drug
Causal Inference
development. Significant efforts have
been made to distribute the large num-
Tuesday, August 4
ber of section activities across the six
8:30 a.m. to 10:20 a.m.
days, including Sunday afternoon and
Adaptive Design: Where Are We Now?
Thursday morning.
CE courses and invited sessions orga-
Wednesday, August 5
nized by the section this year include
2:00 p.m. to 3:50 p.m.
the following:
Issues in Translating Innovative Phase I
Designs Into Oncology Trials
CE Courses
August 3, 8:30 a.m. – 5:00 p.m.
Thursday, August 6
Dose-Finding Studies: Methods and
8:30 a.m. to 10:20 a.m.
Implementation
Pharmacokinetic and
Instructors: Frank Bretz of Norvartis
Pharmacodynamic Modeling
Switzerland and Jose C. Pinheiro of
Novartis Pharmaceutical
In addition to the above sessions,
the section is cosponsoring 21 invited
August 3, 1:00 p.m. – 5:00 p.m.
sessions.
Evaluating Probability of Success
The Biopharmaceutical Section will
for Internal Decisionmaking in Early
again give awards to presenters for the
Drug Development
best contributed and best student papers.
Instructors: Martin King, Narinder
The awards from 2008 will be presented
Nangia, and Jane Qian of Abbott
at the Biopharmaceutical Section meet-
Laboratories
ing and mixer. Information about sec-
tion activities will be available at the
August 4, 8:30 a.m. – 5:00 p.m.
mixer, and members will have a chance
Analysis of Clinical Trials: Theory
to network with others and give feedback
and Applications
on section activities. We look forward to
Instructors: Devan V. Mehrotra of
seeing you in DC this August. n
Merck Research Laboratories, Alexei A.
Dmitrienko of Eli Lilly and Company,
and Keaven Anderson of Merck &
Co., Inc.
68 AmstAt News JUNE 2009
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100